Bridgeway Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-135,500
| Closed | -$534K | – | 1343 |
|
|
2021
Q4 | $534K | Sell |
135,500
-244,592
| -64% | -$964K | 0.01% | 965 |
|
|
2021
Q3 | $1.83M | Sell |
380,092
-20,000
| -5% | -$96.2K | 0.03% | 656 |
|
|
2021
Q2 | $1.84M | Sell |
400,092
-74,500
| -16% | -$342K | 0.03% | 653 |
|
|
2021
Q1 | $2.79M | Sell |
474,592
-353,600
| -43% | -$2.08M | 0.05% | 479 |
|
|
2020
Q4 | $2.83M | Buy |
828,192
+429,800
| +108% | +$1.47M | 0.06% | 387 |
|
|
2020
Q3 | $574K | Hold |
398,392
| – | – | 0.01% | 838 |
|
|
2020
Q2 | $795K | Buy |
398,392
+104,792
| +36% | +$209K | 0.02% | 729 |
|
|
2020
Q1 | $573K | Buy |
+293,600
| New | +$573K | 0.01% | 720 |
|